share_log

Shanghai Kinlita Chemical (SZSE:300225) Is Doing The Right Things To Multiply Its Share Price

Shanghai Kinlita Chemical (SZSE:300225) Is Doing The Right Things To Multiply Its Share Price

金力泰化工(深交所:300225)正在採取正確的措施來增加其股價。
Simply Wall St ·  07/11 21:36

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. So when we looked at Shanghai Kinlita Chemical (SZSE:300225) and its trend of ROCE, we really liked what we saw.

如果你在尋找下一款多袋裝機時不確定從哪裏開始,那麼你應該注意一些關鍵趨勢。除其他外,我們希望看到兩件事:首先,動用資本回報率(ROCE)的增長,其次,公司的資本使用量擴大。如果你看到這一點,這通常意味着它是一家擁有良好商業模式和大量盈利再投資機會的公司。因此,當我們查看上海金力泰化學(SZSE: 300225)及其投資回報率的趨勢時,我們真的很喜歡我們所看到的。

What Is Return On Capital Employed (ROCE)?

什麼是資本使用回報率(ROCE)?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Shanghai Kinlita Chemical:

對於那些不知道的人來說,ROCE是衡量公司年度稅前利潤(其回報率)的指標,相對於該業務使用的資本。分析師使用這個公式來計算上海金力泰化工的計算公式:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)

0.027 = CN¥23m ÷ (CN¥1.3b - CN¥421m) (Based on the trailing twelve months to March 2024).

0.027 = 2300萬元人民幣 ÷(13元人民幣至4.21億元人民幣)(基於截至2024年3月的過去十二個月)。

So, Shanghai Kinlita Chemical has an ROCE of 2.7%. Ultimately, that's a low return and it under-performs the Chemicals industry average of 5.5%.

因此,上海金力泰化工的投資回報率爲2.7%。歸根結底,這是一個低迴報,其表現低於化工行業5.5%的平均水平。

big
SZSE:300225 Return on Capital Employed July 12th 2024
SZSE: 300225 2024 年 7 月 12 日動用資本回報率

Historical performance is a great place to start when researching a stock so above you can see the gauge for Shanghai Kinlita Chemical's ROCE against it's prior returns. If you'd like to look at how Shanghai Kinlita Chemical has performed in the past in other metrics, you can view this free graph of Shanghai Kinlita Chemical's past earnings, revenue and cash flow.

歷史表現是研究股票的絕佳起點,因此在上方您可以看到上海金立泰化工的投資回報率與先前回報率對比的指標。如果你想在其他指標中查看上海金力達化工過去的表現,你可以查看這張上海金力達化工過去的收益、收入和現金流的免費圖表。

So How Is Shanghai Kinlita Chemical's ROCE Trending?

那麼上海金力泰化工的投資回報率走勢如何?

Shanghai Kinlita Chemical has broken into the black (profitability) and we're sure it's a sight for sore eyes. While the business was unprofitable in the past, it's now turned things around and is earning 2.7% on its capital. While returns have increased, the amount of capital employed by Shanghai Kinlita Chemical has remained flat over the period. So while we're happy that the business is more efficient, just keep in mind that could mean that going forward the business is lacking areas to invest internally for growth. Because in the end, a business can only get so efficient.

上海金立達化工已陷入虧損(盈利能力),我們確信這是一個好景象。儘管該業務過去無利可圖,但現在已經扭轉了局面,其資本收益爲2.7%。儘管回報率有所增加,但在此期間,上海金立泰化工所使用的資本金額一直持平。因此,儘管我們對業務效率提高感到高興,但請記住,這可能意味着未來該業務缺乏內部投資以促進增長的領域。因爲歸根結底,企業只能變得如此高效。

On a side note, we noticed that the improvement in ROCE appears to be partly fueled by an increase in current liabilities. Effectively this means that suppliers or short-term creditors are now funding 33% of the business, which is more than it was five years ago. It's worth keeping an eye on this because as the percentage of current liabilities to total assets increases, some aspects of risk also increase.

順便說一句,我們注意到,投資回報率的改善似乎部分是由流動負債的增加推動的。實際上,這意味着供應商或短期債權人現在爲該業務的33%提供了資金,這比五年前還要多。值得關注這個問題,因爲隨着流動負債佔總資產的百分比的增加,風險的某些方面也會增加。

What We Can Learn From Shanghai Kinlita Chemical's ROCE

我們可以從上海金立化工的ROCE中學到什麼

As discussed above, Shanghai Kinlita Chemical appears to be getting more proficient at generating returns since capital employed has remained flat but earnings (before interest and tax) are up. Investors may not be impressed by the favorable underlying trends yet because over the last five years the stock has only returned 6.9% to shareholders. Given that, we'd look further into this stock in case it has more traits that could make it multiply in the long term.

如上所述,上海金立達化工似乎越來越擅長創造回報,因爲資本利用率保持平穩,但收益(不計利息和稅收)有所增加。有利的潛在趨勢可能還不會給投資者留下深刻的印象,因爲在過去五年中,該股向股東的回報率僅爲6.9%。有鑑於此,我們將進一步研究這隻股票,以防它具有更多可以使其長期成倍增長的特徵。

One final note, you should learn about the 3 warning signs we've spotted with Shanghai Kinlita Chemical (including 1 which can't be ignored) .

最後一點是,你應該了解一下我們在上海金力泰化工發現的3個警告信號(包括一個不容忽視的信號)。

While Shanghai Kinlita Chemical isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

儘管上海金立達化工的回報率並不高,但請查看這份免費的股票回報率高、資產負債表穩健的公司名單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件至 editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論